跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMGEVITA adalimumab (rch) 80mg/0.8mL injection solution syringe within a pen injector - TGA Drug Approval Details
Approvals
/
TGA
/
AMGEVITA adalimumab (rch) 80mg/0.8mL injection solution syringe within a pen injector
Approved
STANDARD
AMGEVITA adalimumab (rch) 80mg/0.8mL injection solution syringe within a pen injector
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
d414f2f58489eff1
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
d414f2f58489eff1
Product Name
AMGEVITA adalimumab (rch) 80mg/0.8mL injection solution syringe within a pen injector
Artg Id
486685
Artg Name
AMGEVITA adalimumab (rch) 80mg/0.8mL injection solution syringe within a pen injector
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2025-09-23
Registration Type
Medicine
Therapeutic Good Type
Medicines
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
d414f2f58489eff1
Type
Standard
Back to TGA Approvals